BR112019001605A2 - processo para a preparação de proteína ou peptídeo - Google Patents

processo para a preparação de proteína ou peptídeo

Info

Publication number
BR112019001605A2
BR112019001605A2 BR112019001605-8A BR112019001605A BR112019001605A2 BR 112019001605 A2 BR112019001605 A2 BR 112019001605A2 BR 112019001605 A BR112019001605 A BR 112019001605A BR 112019001605 A2 BR112019001605 A2 BR 112019001605A2
Authority
BR
Brazil
Prior art keywords
peptide
preparing protein
proteins
derivatives
preparing
Prior art date
Application number
BR112019001605-8A
Other languages
English (en)
Inventor
Jagan Mohan Reddy Veluri
Sairam Mustoori
Srinivasulu Reddy Yeruva
Tapas Barui
Jyothishwaran Jyothishwaran
Venkata Sada Siva Rao Kanduri
Tajamul Furkhan
Krishnan Malolanarasimhan
Murugan Ravichandran Narayanasamy
Chaitanyakumar Kedari
Vasker Rakesh Goud
Sahejad Desai
Original Assignee
Dr. Reddy´S Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy´S Laboratories Limited filed Critical Dr. Reddy´S Laboratories Limited
Publication of BR112019001605A2 publication Critical patent/BR112019001605A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

a presente invenção refere-se a um processo para a preparação de peptídeos ou proteínas ou derivados dos mesmos pela expressão de oligonucleotídeo sintético que codifica a proteína ou peptídeo desejado na célula procariótica como construto de fusão de ubiquitina.
BR112019001605-8A 2016-07-27 2017-07-25 processo para a preparação de proteína ou peptídeo BR112019001605A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201641025693 2016-07-27
IN201641025693 2016-07-27
PCT/IB2017/054505 WO2018020417A1 (en) 2016-07-27 2017-07-25 Process for preparation of protein or peptide

Publications (1)

Publication Number Publication Date
BR112019001605A2 true BR112019001605A2 (pt) 2019-04-30

Family

ID=61016917

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019001605-8A BR112019001605A2 (pt) 2016-07-27 2017-07-25 processo para a preparação de proteína ou peptídeo

Country Status (5)

Country Link
US (1) US20190263880A1 (pt)
EP (1) EP3491006A4 (pt)
JP (1) JP2019528686A (pt)
BR (1) BR112019001605A2 (pt)
WO (1) WO2018020417A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201946930A (zh) * 2018-05-15 2019-12-16 展旺生命科技股份有限公司 製備利拉魯肽衍生物的方法
US20220389072A1 (en) * 2018-09-13 2022-12-08 Bhargava Sajjala Process for production of soluble recombinant peptides
WO2020127476A1 (en) 2018-12-19 2020-06-25 Krka, D.D., Novo Mesto Pharmaceutical composition comprising glp-1 analogue
TWI738260B (zh) * 2019-03-25 2021-09-01 台灣神隆股份有限公司 純化利拉魯肽之方法
WO2021123228A1 (en) 2019-12-18 2021-06-24 Krka, D.D., Novo Mesto Pharmaceutical composition comprising glp-1 analogue
WO2022064517A1 (en) * 2020-09-23 2022-03-31 Dr. Reddy's Laboratories Limited A process for the preparation of semaglutide and semapeptide
CN114031681B (zh) * 2022-01-11 2022-04-12 浙江湃肽生物有限公司深圳分公司 一种利拉鲁肽类似物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004044007A1 (en) * 2002-11-12 2004-05-27 Bresagen Limited Production of ubiquitin fusion proteins
WO2016059609A1 (en) * 2014-10-17 2016-04-21 Dr. Reddy' S Laboratories Limited Acylation process for preparation of liraglutide
WO2017021819A1 (en) * 2015-07-31 2017-02-09 Dr. Reddy’S Laboratories Limited Process for preparation of protein or peptide

Also Published As

Publication number Publication date
EP3491006A1 (en) 2019-06-05
WO2018020417A1 (en) 2018-02-01
EP3491006A4 (en) 2020-03-11
US20190263880A1 (en) 2019-08-29
JP2019528686A (ja) 2019-10-17

Similar Documents

Publication Publication Date Title
BR112019001605A2 (pt) processo para a preparação de proteína ou peptídeo
UY37463A (es) Proteínas de unión
BR112016022841A2 (pt) cadeia j modificada
BR112018007017A2 (pt) polipeptídeos
EA201491494A1 (ru) Нацеливание на гликаны хондроитинсульфаты
MX2017006866A (es) Pares de unión para producción de péptidos.
ECSP15013209A (es) Moléculas de enlace a il-18
AR099462A1 (es) Unidad de ultrafiltración para el intercambio continuo de medio o tampón de una solución proteica
EA201492221A1 (ru) Полипептиды, имеющие активность трансгалактозилирования
CR20180597A (es) Péptidos de tránsito dual para el direccionamiento a polipéptidos
BR112017013956A8 (pt) proteínas de fusão de citocinas
IL250646A0 (en) A process for conjugating a peptide or protein with a reagent containing a leaving group that includes a peg moiety
UY36867A (es) Péptidos de tránsito al cloroplasto
UY36678A (es) Anticuerpos anti-fcrn.
MD20150109A2 (ro) Construcţii proteice mitocondriale şi utilizările acestora
AR112069A1 (es) Inmunoglobulinas que fijan aggrecan
MX2021001418A (es) Produccion de proteinas heteromultimericas usando celulas de mamifero.
AR115695A1 (es) Moléculas proteicas multifuncionales que comprenden decorina y uso de estas
AR090668A1 (es) Anticuerpo anti-adamts-5, derivados y usos del mismo
ECSP18046820A (es) Polipéptidos que inhiben cd40l
PH12019501064A1 (en) Ras PROTIEIN DEGRADATION INDUCING MOLECULE AND PHARMACEUTICAL COMPOSITION
BR112015004629A2 (pt) polipeptídeos de clostridium difficile como vacinas
CO2017011431A2 (es) Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina
BR112017013574A2 (pt) conjugados de aminoácido e peptídeo e usos dos mesmos
BR112017001463A2 (pt) célula hospedeira melhorada para produzir proteínas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2594 DE 24-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.